R-Zero
The future of R-Zero
COVID-19 exposed how vulnerable we are to infectious diseases.
But the challenge is bigger than Coronavirus alone.
When it comes to infection prevention, we need a new normal.
Norovirus impacts 19 to 21 million Americans every year, and costs $2 billion annually. Influenza impacts 30 to 40 million Americans every year and costs $10.4 billion annually. E. coli impacts 265 thousand Americans every year.
At R-Zero, we’ve developed a suite of solutions designed to greatly reduce the staggering damage each one of those viruses causes to our health and the health of our economy.
We’re establishing a new standard for public health. One to address and overcome the challenges we face today and in the future.
We are a biosafety company dedicated to making safer everyday spaces and common places. We thoughtfully design the most effective technologies and protocols to reduce our world of deadly pathogens—today and forever.
